F
F. Travert
Researcher at University of Paris
Publications - 25
Citations - 8750
F. Travert is an academic researcher from University of Paris. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 12, co-authored 22 publications receiving 8074 citations. Previous affiliations of F. Travert include Paris Diderot University & New York City Fire Department.
Papers
More filters
Journal ArticleDOI
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes
David B. Dunger,Sylvaine F. A. Bruggraber,Adrian Mander,M. Loredana Marcovecchio,Timothy Tree,Piotr Jaroslaw Chmura,Mikael Knip,Anke M. Schulte,Chantal Mathieu,Cyril Mathieu,Pieter Gillard,Kristina Casteels,Lutgart Overbergh,Clarissa Wallace,M. Evans,Ajay Thankamony,Emile Hendriks,Sfa Bruggraber,Mark Peakman,Noel G. Morgan,Steven Richardson,J. Todd,Linda S. Wicker,Colin M. Dayan,Mohammad Alhadj Ali,Thomas R. Pieber,DL Eizirik,Miriam Cnop,Soeren Brunak,Flemming Pociot,Jesper Johannesen,Peter Rossing,C. Legido Quigley,Roberto Mallone,Raphael Scharfmann,Christian Boitard,Timo Otonkoski,Riitta Veijola,Riitta Lahesmaa,M. Oresic,Jorma Toppari,Thomas Danne,AG Ziegler,Peter Achenbach,Teresa Rodriguez-Calvo,Michele Solimena,Ezio Bonifacio,Sandra Speier,R.W. Holl,Francesco Dotta,Francesco Chiarelli,Paula M Marchetti,Emanuele Bosi,Stefano Cianfarani,Paolo Ciampalini,C De Beaufort,Knut Dahl-Jørgensen,Torild Skrivarhaug,Geir Joner,Lars Krogvold,Przemysława Jarosz-Chobot,Tadej Battelino,Bernard Thorens,Martin Gotthardt,Bart O. Roep,T. Nikolic,Arnaud Zaldumbide,Åke Lernmark,Markus Lundgren,G. Costecalde,Thorsten Strube,Amanda Schulte,Achim Dipl Ing Nitsche,Matthias von Herrath,J Wesley,A Napolitano-Rosen,Matthias H. Thomas,N. C. Schloot,Allison B. Goldfine,Frank Waldron-Lynch,Jill E. Kompa,Aruna Vedala,Nina Hartmann,Gemma Muñiz Nicolás,Jean Van Rampelbergh,Nicolas Bovy,S. Dutta,J. Soderberg,F. Martin,Gina Agiostratidou,Anne Koralova,Rene Willemsen,A. Smith,B Anand,V Puthi,Sagen Zac-Varghese,Vishnu Datta,Rayanne Soraia Aguiar de Melo Dias,R. Sundaram,Bina Vaidya,CJ Patterson,Klara Owen,Bruno Piel,Schott Heller,TR Randell,T Gazis,E. Bismuth Reismen,Jean-Claude Carel,J.P. Riveline,Jean-François Gautier,F. Andreelli,F. Travert,Emmanuel Cosson,Alfred Penfornis,Catherine Petit,Benoit Feve,Nadine Lucidarme,J. P. Beressi,Catherine C. Ajzenman,A Radu,S. Greteau-Hamoumou,Cecile Bibal,T. Meißner,Bettina Heidtmann,Sonia Toni,Birgit Rami-Merhar,Bart Eeckhout,Bernard Peene,N. Vantongerloo,Toon Maes,L. Gommers,Juan Vela,Esther Latres +132 more
TL;DR: In this article , the authors developed a Master Protocol, based on the "backbone" of the INNODIA natural history study, which could improve the delivery of phase 2 studies exploring the use of single or combinations of Investigational Medicinal Products (IMPs), designed to prevent or reverse declines in beta-cell function in individuals with newly diagnosed type 1 diabetes.
Journal ArticleDOI
Association of common variants in NPPA and NPPB with blood pressure does not translate into kidney damage in a general population study.
S. Maimaitiming,Ronan Roussel,Samy Hadjadj,Frédéric Fumeron,Roberte Aubert,Nathalie Emery,Gilberto Velho,Kamel Mohammedi,F. Travert,Jean Tichet,François Alhenc-Gelas,Beverley Balkau,Michel Marre +12 more
TL;DR: No haplotype, including GCG, the one combining the three rare alleles, was associated with incident patients of either microalbuminuria or glomerular filtration rate, consistent with a lack of effect on clinical renal outcomes, and showed that even replicated and biologically plausible genetic association studies based on surrogate markers do not easily translate into clinically meaningful prognosis.
Journal ArticleDOI
Outpatient measurement of arterial stiffness in patients with type 2 diabetes and obesity.
Kamel Mohammedi,Kamel Mohammedi,Aminata Compaoré,Louis Potier,Louis Potier,Louis Potier,Narimène Belhatem,Narimène Belhatem,Marilyne Feron,Nadia Matallah,Nadia Matallah,F. Travert,F. Travert,F. Travert,Boris Hansel,Boris Hansel,Boris Hansel,Gilberto Velho,Ronan Roussel,Ronan Roussel,Ronan Roussel,M. Hallab,Michel Marre,Michel Marre,Michel Marre +24 more
TL;DR: Patients with type 2 diabetes mellitus or obesity and healthy subjects in an outpatient setting are compared onulse wave velocity, a marker of arterial stiffness, to compare PWV.
Journal ArticleDOI
Intensifying glycaemic control with insulin reduces adiponectin and its HMW isoform moderately in type 2, but not in type 1, diabetes
C. Abi Khalil,C. Abi Khalil,Kamel Mohammedi,Kamel Mohammedi,Roberte Aubert,F. Travert,Samy Hadjadj,Ronan Roussel,Ronan Roussel,Frédéric Fumeron,Frédéric Fumeron,Michel Marre,Michel Marre +12 more
TL;DR: In this article, the impact of diabetes control on adiponectin (ADPN) levels was evaluated in 15 T1D and 48 T2D patients with HbA 1c greater than 10% at hospitalization for uncontrolled diabetes.
Journal ArticleDOI
Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real‐life experience from a national reference network
Héléna Mosbah,Mc. Vantyghem,Estelle Nobecourt,Fabrizio Andreelli,F. Archambeaud,Elise Bismuth,Claire Briet,Maryse Cartigny,B. Chevalier,Bruno Donadille,Anne Daguenel,M. Fichet,J.F. Gautier,Sonja Janmaat,Isabelle Jéru,C. Legagneur,L. Leguier,Jean-Michel Maître,E. Mongeois,Christine Poitou,Eric Renard,Yves Reznik,Adrian Spiteri,F. Travert,Bruno Vergès,Jamila Zammouri,Corinne Vigouroux,Camille Vatier +27 more
TL;DR: